Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accounts Payables: 2022

Historic Accounts Payables for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2022 value amounting to $2.7 million.

  • Lexeo Therapeutics' Accounts Payables was N/A to $2.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2022, which is N/A change from last year.
  • Per Lexeo Therapeutics' latest filing, its Accounts Payables stood at $2.7 million for FY2022.
  • Lexeo Therapeutics' Accounts Payables' 5-year high stood at $2.7 million during FY2022, with a 5-year trough of $2.7 million in FY2022.
  • Its 1-year average for Accounts Payables is $2.7 million, with a median of $2.7 million in 2022.